Hormone Replacement Therapy (HRT) Over 70: A Balanced Guide

Dr. Shweta Patel, MD, FACOG

Board-certified OB/GYN • U.S. Navy veteran (13 years) • Author, The Book of Hormones • Founder, Gaya Wellness

Published August 7, 2025 • Updated May 3, 2026

If you are over 70 and asking about hormone replacement therapy, I want to start with the truth: this is not a simple yes or no. It is not good medicine to tell every 72-year-old woman that hormones are forbidden. It is also not good medicine to tell her that hormones will reverse aging, prevent dementia, protect her heart, fix her weight, and make every symptom disappear.

At this age, hormone decisions require more precision. Are we talking about systemic estrogen for hot flashes and night sweats? Low-dose vaginal estrogen for dryness, urinary symptoms, or pain with sex? Continuing a low-dose plan that began years ago? Starting for the first time after two decades without a period? These are different clinical situations.

My job is not to sell hormones or withhold them reflexively. My job is to ask what we are treating, how long you have been menopausal, what risks you carry, what route is safest, and whether the expected benefit is strong enough to justify exposure in your actual body.

Why Age 70 Changes the Conversation

Age matters because baseline risk changes. A woman at 52 with severe night sweats, normal blood pressure, no clot history, and no breast cancer history is not the same as a woman at 73 with coronary disease, diabetes, migraines with aura, and a prior deep vein thrombosis. The medication may have the same name, but the context is different.

The NAMS 2022 hormone therapy position statement is the clearest framework I use with patients. It says the benefit-risk profile is most favorable when hormone therapy is started in healthy women younger than 60 or within 10 years of menopause. It also says initiation after 60 needs careful consideration because absolute risks of coronary heart disease, stroke, venous thromboembolism, and dementia rise with age.

That does not mean a 70-year-old must automatically stop a therapy that has been helping her. It means we should not use autopilot. I want to know why she is taking it, whether she still needs it, whether the dose is still appropriate, whether the route should change, and whether her health history has changed since the prescription began.

Starting HRT After 70 Is Not the Same as Continuing It

This distinction is everything. Starting systemic HRT for the first time after age 70 is usually a higher-risk decision than continuing a carefully selected plan that began earlier in menopause. If a woman is 72 and has never used systemic hormones, I slow down. I review the severity of symptoms, the time since menopause, cardiovascular risk, clot history, breast history, stroke risk, liver disease, blood pressure, lipids, A1c, smoking history, medications, and whether there is unexplained bleeding.

Continuing HRT after 70 can be reasonable in selected women. NAMS states that hormone therapy does not need to be routinely stopped after age 60 or 65. For women with persistent vasomotor symptoms, poor sleep when tapering, or elevated fracture risk when other therapies are not appropriate, long-term use may be considered after individualized review.

What I do not like is indefinite renewal without evaluation. If nobody has discussed your dose, route, mammogram status, blood pressure, bleeding history, or uterus status in years, that is not hormone care. That is refill inertia. If you need a physician-led review, Gaya offers hormone replacement therapy for women with attention to symptoms, risk, and follow-up rather than blanket rules.

Route, Dose, and Progesterone Matter More After 70

When patients say “I am on HRT,” I always ask what kind. A pill, patch, gel, spray, compounded cream, pellet, vaginal tablet, vaginal ring, and progesterone capsule are not interchangeable. Route changes exposure. Dose changes risk. Uterus status changes the safety plan.

Oral estrogen goes through the liver first and can affect clotting factors and triglycerides. Transdermal estradiol, delivered through the skin as a patch, gel, or spray, avoids that first-pass liver effect. The American College of Obstetricians and Gynecologists has noted that oral estrogen may have a prothrombotic effect, while transdermal estrogen appears to have little or no effect on prothrombotic substances. That does not make transdermal estrogen risk-free. It means route belongs in the risk conversation.

Dose also matters. Over 70, I am not trying to chase a lab number into a youthful range. I am trying to use the lowest effective dose for a defined symptom or risk goal. If a woman needs treatment only for vaginal dryness or urinary symptoms, systemic escalation may be the wrong tool. If she still has severe night sweats despite prior attempts to taper, systemic therapy may be discussed, but the plan should be conservative and monitored.

If you have a uterus and use systemic estrogen, you generally need progesterone or another endometrial-protective strategy. Estrogen alone can stimulate the uterine lining. If you have had a hysterectomy, progesterone may not be needed for uterine protection. This is why surgical history and bleeding history are not details. They are safety data.

Who Should Usually Avoid Systemic HRT

Some women over 70 should not use systemic hormone therapy unless a specialist has a compelling reason and a monitoring plan. I am usually cautious or avoid it with unexplained vaginal bleeding, prior estrogen-sensitive breast cancer, prior stroke, heart attack, pulmonary embolism, deep vein thrombosis, known high-risk clotting disorder, active liver disease, or uncontrolled cardiovascular risk.

The Mayo Clinic explains that starting hormone therapy at 60 or older, or more than 10 years after menopause, increases the risk of serious complications. That statement is not meant to shame women. It is meant to make the decision honest.

I am also cautious with pellets in older women. Pellets can create prolonged hormone exposure that is harder to adjust quickly if bleeding, breast tenderness, mood changes, acne, hair changes, or supraphysiologic levels appear. At 70, adjustability matters. I want to be able to lower, pause, or stop a medication when the body gives us a reason.

Contraindications do not mean you are abandoned. Nonhormonal hot flash medications, sleep evaluation, pelvic floor therapy, vaginal moisturizers, low-dose local estrogen when appropriate, bone medications, cardiometabolic care, and sexual health treatment can all be part of a serious plan.

Vaginal Estrogen Is a Different Conversation

Many women over 70 are not asking for systemic HRT. They are asking for relief from vaginal dryness, burning, tearing, painful intimacy, recurrent urinary symptoms, urgency, or tissue fragility. That is genitourinary syndrome of menopause, and it often worsens with prolonged estrogen deficiency.

Low-dose vaginal estrogen is different from systemic estrogen. It is placed locally as a cream, tablet, insert, or ring and generally has much lower systemic absorption than whole-body therapy. For many older women, the risk-benefit conversation for local treatment is far more favorable than for starting systemic estrogen after 70.

This is where blanket fear does real harm. A woman may be told she is “too old for estrogen” when she actually needs local tissue treatment, urinary evaluation, pelvic floor support, or vaginal rejuvenation options. Pain with sex is not a character flaw. Recurrent urinary discomfort is not just aging. These symptoms deserve evaluation through a menopause-literate clinician.

The FDA approved menopausal hormone therapy label changes in February 2026, including removal of certain boxed-warning language related to cardiovascular disease, breast cancer, and probable dementia from the first batch of products. I see that as a correction away from overbroad fear, not as permission to prescribe casually.

How I Evaluate Women Over 70 at Gaya

My first question is always, “What are we treating?” Hot flashes, night sweats, insomnia, vaginal dryness, urinary symptoms, mood changes, libido changes, joint pain, bone loss, and weight gain can overlap, but they do not all require the same treatment.

Then I map timing. When was your final period? Did you have surgical menopause? Did chemotherapy or ovarian removal change your timeline? Have you taken hormones before? If you stopped, did symptoms return? If you continued, who has been reassessing the plan?

I review contraindications and risk factors. That includes breast imaging status, abnormal bleeding, clot history, stroke history, heart disease, migraine aura, tobacco, blood pressure, cholesterol, diabetes risk, liver disease, family history, and current medications. I also review whether symptoms could be driven by thyroid disease, anemia, sleep apnea, medication side effects, depression, alcohol, insulin resistance, or another condition.

This is also where I separate hormone care from hype. If your goal is relief from severe night sweats or painful vaginal symptoms, we can define and measure that. If your goal is anti-aging, I slow down. Gaya supports long-term health through Her Longevity, menopause care, and cardiometabolic planning, but systemic estrogen after 70 is not a general anti-aging prescription.

What I Tell My Patients Over 70

I tell them that hormones are not a moral issue. Taking HRT does not mean you are vain or reckless. Declining HRT does not mean you are uninformed. The question is whether the therapy fits your symptoms, history, risk profile, and goals today.

If you are already on HRT, do not stop abruptly without a plan unless your clinician gives you an urgent safety reason. Ask for a structured review. What is the indication? Is the dose still the lowest effective dose? Is the route appropriate? Do you still need progesterone? Have your risks changed? Should we try lowering the dose? Should vaginal symptoms be treated locally instead?

If you are over 70 and want to start systemic HRT for the first time, expect a more careful evaluation. That is not dismissal. That is the standard you deserve. In some cases, we may use nonhormonal options first. In others, we may treat vaginal symptoms locally. Sometimes the real priority is blood pressure, lipids, insulin resistance, bone density, sleep, or medication review.

Inside Hormonal Agency™, I build hormone decisions around symptoms, timeline, uterus status, risk, labs, prior treatment, and follow-up. We also address related drivers such as perimenopause history, hot flashes, night sweats, stubborn weight gain, and medical weight changes through Weight Loss Concierge when appropriate.

The best hormone plan is not the loudest plan. It is the plan that tells the truth, respects your symptoms, and adjusts when your body or your risk changes.

Dr. Shweta Patel, MD, FACOG

Board-certified OB/GYN, U.S. Navy veteran, and founder of Gaya Wellness. Dr. Patel leads physician-managed programs in hormone optimization, menopause hormone therapy, and longevity medicine for women in midlife and beyond.

You have not failed. Your plan did.